Published in Lancet on December 18, 2010
Two years after pandemic influenza A/2009/H1N1: what have we learned? Clin Microbiol Rev (2012) 1.31
Avian influenza A H5N1 virus: a continuous threat to humans. Emerg Microbes Infect (2012) 1.30
Virus-associated hemophagocytic syndrome as a major contributor to death in patients with 2009 influenza A (H1N1) infection. Crit Care (2011) 1.21
The need for worldwide policy and action plans for rare diseases. Acta Paediatr (2012) 1.13
Potential of immunomodulatory agents as adjunct host-directed therapies for multidrug-resistant tuberculosis. BMC Med (2016) 0.83
Virus-host interactomics: new insights and opportunities for antiviral drug discovery. Genome Med (2014) 0.81
Extracorporeal membrane oxygenation for acute respiratory distress syndrome. J Intensive Care (2015) 0.78
Whole-Exome Sequencing Reveals Mutations in Genes Linked to Hemophagocytic Lymphohistiocytosis and Macrophage Activation Syndrome in Fatal Cases of H1N1 Influenza. J Infect Dis (2015) 0.78
Regulation of human NK-cell cytokine and chemokine production by target cell recognition. Blood (2009) 3.46
Predicting mortality risk in patients undergoing venovenous ECMO for ARDS due to influenza A (H1N1) pneumonia: the ECMOnet score. Intensive Care Med (2012) 3.24
Activation of NK cells by an endocytosed receptor for soluble HLA-G. PLoS Biol (2006) 2.08
Integrin-dependent organization and bidirectional vesicular traffic at cytotoxic immune synapses. Immunity (2009) 1.74
Prolonged extracorporeal membrane oxygenation and circulatory support as bridge to lung transplant. Ann Thorac Surg (2008) 1.73
Primary human tumor cells expressing CD155 impair tumor targeting by down-regulating DNAM-1 on NK cells. J Immunol (2009) 1.38
ORAI1-mediated calcium influx is required for human cytotoxic lymphocyte degranulation and target cell lysis. Proc Natl Acad Sci U S A (2011) 1.35
Spectrum of clinical presentations in familial hemophagocytic lymphohistiocytosis type 5 patients with mutations in STXBP2. Blood (2010) 1.28
Synergistic signals for natural cytotoxicity are required to overcome inhibition by c-Cbl ubiquitin ligase. Immunity (2010) 1.25
Identification of lectin-like receptors expressed by antigen presenting cells and neutrophils and their mapping to a novel gene complex. Immunogenetics (2004) 1.19
Different NK cell-activating receptors preferentially recruit Rab27a or Munc13-4 to perforin-containing granules for cytotoxicity. Blood (2009) 1.16
Subtle differences in CTL cytotoxicity determine susceptibility to hemophagocytic lymphohistiocytosis in mice and humans with Chediak-Higashi syndrome. Blood (2011) 1.12
Natural killer cells in human autoimmunity. Curr Opin Immunol (2009) 1.11
A novel intellectual disability syndrome caused by GPI anchor deficiency due to homozygous mutations in PIGT. J Med Genet (2013) 1.08
Clinical presentation of Griscelli syndrome type 2 and spectrum of RAB27A mutations. Pediatr Blood Cancer (2010) 1.01
IFN-α production by plasmacytoid dendritic cells stimulated with RNA-containing immune complexes is promoted by NK cells via MIP-1β and LFA-1. J Immunol (2011) 0.98
Epigenetic regulation of NK cell differentiation and effector functions. Front Immunol (2013) 0.96
Surface CD107a/LAMP-1 protects natural killer cells from degranulation-associated damage. Blood (2013) 0.96
Familial hemophagocytic lymphohistiocytosis type 3 (FHL3) caused by deep intronic mutation and inversion in UNC13D. Blood (2011) 0.95
Epstein-Barr virus coinfection in children boosts cytomegalovirus-induced differentiation of natural killer cells. J Virol (2013) 0.95
Updates on histiocytic disorders. Pediatr Blood Cancer (2014) 0.94
Extracorporeal membrane oxygenation in pediatric recipients of hematopoietic stem cell transplantation: an updated analysis of the Extracorporeal Life Support Organization experience. Intensive Care Med (2014) 0.94
Analysis of the KIR repertoire in human NK cells by flow cytometry. Methods Mol Biol (2010) 0.93
NK cell-mediated targeting of human cancer and possibilities for new means of immunotherapy. Cancer Immunol Immunother (2008) 0.92
Insights into NK cell biology from human genetics and disease associations. Cell Mol Life Sci (2011) 0.90
Kinome analysis of receptor-induced phosphorylation in human natural killer cells. PLoS One (2012) 0.87
Diversification and Functional Specialization of Human NK Cell Subsets. Curr Top Microbiol Immunol (2016) 0.82
Local lactate and histamine changes in small bowel circulation measured by microdialysis in pig hemorrhagic shock. Shock (2002) 0.81
Immunomodulatory activity of commonly used drugs on Fc-receptor-mediated human natural killer cell activation. Cancer Immunol Immunother (2014) 0.81
Development of classical Hodgkin's lymphoma in an adult with biallelic STXBP2 mutations. Haematologica (2012) 0.81
Treatment of familial hemophagocytic lymphohistiocytosis with third-party mesenchymal stromal cells. Stem Cells Dev (2012) 0.80
CT in the evaluation of patients on ECMO due to acute respiratory failure. Pediatr Radiol (2002) 0.80
Novel deep intronic and missense UNC13D mutations in familial haemophagocytic lymphohistiocytosis type 3. Br J Haematol (2013) 0.80
Hemophagocytic syndrome in a 4-month-old infant with biotinidase deficiency. Pediatr Blood Cancer (2011) 0.79
Natural killer cells: biology, physiology and medicine--part 1. J Innate Immun (2011) 0.79
Novel STAT3 mutation causing hyper-IgE syndrome: studies of the clinical course and immunopathology. J Clin Immunol (2014) 0.79
Lymphocyte effector functions: armed for destruction? Curr Opin Immunol (2007) 0.78
Natural killer cells: biology, physiology and medicine - part 2. J Innate Immun (2011) 0.78
Sensitive and viable quantification of inside-out signals for LFA-1 activation in human cytotoxic lymphocytes by flow cytometry. J Immunol Methods (2011) 0.77
Systemic lupus erythematosus immune complexes increase the expression of SLAM family members CD319 (CRACC) and CD229 (LY-9) on plasmacytoid dendritic cells and CD319 on CD56(dim) NK cells. J Immunol (2013) 0.77
Alemtuzumab treatment for hemophagocytic lymphohistiocytosis. Nat Rev Clin Oncol (2010) 0.77
MRI of the brain and thorax during extracorporeal membrane oxygenation: preliminary report from a pig model. ASAIO J (2006) 0.77
Unusual functional manifestations of a novel STX11 frameshift mutation in two infants with familial hemophagocytic lymphohistiocytosis type 4 (FHL4). Pediatr Blood Cancer (2010) 0.77
Experimental extracorporeal membrane oxygenation reduces central venous pressure: an adjunct to control of venous hemorrhage? Perfusion (2010) 0.77
Does permissive hypoxaemia during extracorporeal membrane oxygenation cause long-term neurological impairment?: A study in patients with H1N1-induced severe respiratory failure. Eur J Anaesthesiol (2017) 0.77
Neonates with congenital diaphragmatic hernia have smaller neck veins than other neonates-An alternative route for ECMO cannulation. J Pediatr Surg (2002) 0.77
Arrestin NK cell cytotoxicity. Nat Immunol (2008) 0.76
Cannula Design and Recirculation During Venovenous Extracorporeal Membrane Oxygenation. ASAIO J (2016) 0.75
Lymphocyte cytotoxicity: tug-of-war on microtubules. Blood (2012) 0.75
Comment on Grasso et al.: ECMO criteria for influenza A (H1N1)-associated ARDS: role of transpulmonary pressure. Intensive Care Med (2012) 0.75
Extracorporeal Life Support for severe respiratory failure with special reference to the influenza H1N1 pandemic. Acta Anaesthesiol Scand (2017) 0.75
Functional anti-CD94/NKG2A and anti-CD94/NKG2C autoantibodies in patients with systemic lupus erythematosus. Arthritis Rheumatol (2015) 0.75
Autologous Peripheral Blood Mononuclear Cells as Treatment in Refractory Acute Respiratory Distress Syndrome. Respiration (2015) 0.75
Anti-NKG2A autoantibodies in a patient with systemic lupus erythematosus. Rheumatology (Oxford) (2013) 0.75
Hematopoietic stem cell transplantation of an adolescent with neurological manifestations of homozygous missense PRF1 mutation. Pediatr Blood Cancer (2014) 0.75
PET/CT examination in an anaplastic malignant lymphoma with extensive reactive involvement. Clin Nucl Med (2008) 0.75